ACR Gears Up For Key State Legislative Issues Including AI
ACR joined physician leaders at the AMA summit to address Medicaid, payer issues, physician-led care, wellness, and emerging AI legislation in states.
Read more
President Biden signed the Further Consolidated Appropriations Act, 2024 (H.R. 2882) into law March 23, to fund the U.S. Departments of Labor, Education and Health and Human Services and their programs for the remainder of federal fiscal year (FY) 2024.
The act includes $47.1 billion for the National Institutes of Health (NIH), $378 million (0.8%) below the FY 2023 enacted level, a direct result of a scheduled reduction in 21st Century Cures funding available to appropriators in FY 2024. The American College of Radiology® (ACR®) advocated in support of NIH increases.
NIH received $300 million in new funding that is reflected in increases to nine institutes and centers. The act also:
The Advanced Research Projects Agency for Health (ARPA-H) received $1.5 billion in funding, the same level as provided in FY 2023. The legislation urges ARPA-H to consider funding research on rare cancers that have low survival rates and little advancement in therapeutics.
Another provision of the act supported by ACR is an extension of Protecting Access to Lifesaving Screenings (PALS)-type language to ensure access to coverage for annual screening mammography for women 40 and older with no deductibles or copays.
President Biden recently released his FY 2025 budget proposal, in which he requests Congress increase funding for NIH and $716 million in discretionary funds for NCI. Funding for the Cancer Moonshot program was also incorporated into the proposed budget. ACR has begun advocacy efforts for an increase in NIH funding for FY 2025, asking Congress to provide $53.1 billion to NIH.
For more information, contact Katie Grady, ACR Government Affairs Director.
ACR Gears Up For Key State Legislative Issues Including AI
ACR joined physician leaders at the AMA summit to address Medicaid, payer issues, physician-led care, wellness, and emerging AI legislation in states.
Read more
FDA Updates Guidance on Clinical Decision Support
FDA’s 2026 CDS update clarifies which software is regulated, affirming oversight of image‑analysis tools while exempting certain guideline‑based CDS.
Read moreStates Begin to Introduce Bills for 2026
States launch 2026 sessions with new bills on AI governance, rural radiation therapy, imaging workforce standards, and dose rules.
Read more